MIKKI ROYSTON: Open Payments
NPI 1184356511 · BROUSSARD, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 39 payments from 13 companies in 2025. Trend: 2023 $346 · 2024 $569 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $148 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| PFIZER INC. | 3 | $58 |
| Ardelyx, Inc. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $38 |
| Corium, LLC | 4 | $34 |
| Novo Nordisk Inc | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: VRAYLAR, Auvelity, IBSRELA, AIRSUPRA, REXULTI, ELIQUIS, Azstarys, NURTEC ODT.
Industry payments across LA — which companies pay providers there.
